loadpatents
name:-0.026868104934692
name:-0.012784957885742
name:-0.0091068744659424
Doyle; Kevin James Patent Filings

Doyle; Kevin James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doyle; Kevin James.The latest application filed is for "certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors".

Company Profile
8.13.30
  • Doyle; Kevin James - Essex GB
  • Doyle; Kevin James - Saffron Walden GB
  • Doyle; Kevin James - Saffron Walden Essex GB
  • Doyle; Kevin James - Nottingham GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
Grant 11,117,874 - Lonn , et al. September 14, 2
2021-09-14
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20210238152 - LONN; Hans Roland ;   et al.
2021-08-05
Chemical compounds
Grant 10,793,559 - Anderson , et al. October 6, 2
2020-10-06
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20200247765 - Kind Code
2020-08-06
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors
Grant 10,669,245 - Lonn , et al.
2020-06-02
Chemical Compounds
App 20200071311 - ANDERSON; Niall Andrew ;   et al.
2020-03-05
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20200017455 - LONN; Hans Roland ;   et al.
2020-01-16
Chemical compounds
Grant 10,457,674 - Anderson , et al. Oc
2019-10-29
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
Grant 10,287,258 - Lonn , et al.
2019-05-14
Chemical Compounds
App 20190040051 - ANDERSON; Niall Andrew ;   et al.
2019-02-07
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20180251436 - LONN; Hans Roland ;   et al.
2018-09-06
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20170057938 - LONN; Hans Roland ;   et al.
2017-03-02
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
Grant 9,522,894 - Lonn , et al. December 20, 2
2016-12-20
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors
App 20150210655 - LONN; Hans Roland ;   et al.
2015-07-30
Compounds, compositions and methods comprising oxadiazole derivatives
Grant 8,796,321 - Jones , et al. August 5, 2
2014-08-05
Novel Compound Useful For The Treatment Of Degenerative And Inflammatory Diseases
App 20130217722 - MENET; Christel Jeanne Marie ;   et al.
2013-08-22
Novel Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases
App 20130217664 - MENET; Christel Jeanne Marie ;   et al.
2013-08-22
Compounds, compositions and methods comprising pyrazole derivatives
Grant 8,343,976 - Penrose , et al. January 1, 2
2013-01-01
Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
App 20120264717 - Jones; Graham Peter ;   et al.
2012-10-18
Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
Grant 8,283,351 - Russell , et al. October 9, 2
2012-10-09
Compounds, compositions and methods comprising isoxazole derivatives
Grant 8,236,838 - Jones , et al. August 7, 2
2012-08-07
Compounds, compositions and methods comprising oxadiazole derivatives
Grant 8,207,205 - Jones , et al. June 26, 2
2012-06-26
Compounds, Compositions And Methods Comprising 1,3,4-oxadiazole Derivatives
App 20120136003 - Russell; Michael Geoffrey Neil ;   et al.
2012-05-31
Compounds, Compositions And Methods Comprising Pyridazine Sulfonamide Derivatives
App 20120129858 - Penrose; Stephen David ;   et al.
2012-05-24
Compositions And Methods Comprising Imidazole And Triazole Derivatives
App 20110237528 - Jones; Graham Peter ;   et al.
2011-09-29
Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
App 20100267725 - Russell; Michael Geoffrey Neil ;   et al.
2010-10-21
Compounds, Compositions and Methods Comprising Pyrazole Derivatives
App 20100267741 - Penrose; Stephen David ;   et al.
2010-10-21
Compounds, Compositions and Methods Comprising Pyridazine Derivatives
App 20100267706 - Russell; Michael Geoffrey Neil ;   et al.
2010-10-21
Compounds, compositions and methods comprising heteroaromatic derivatives
App 20100144733 - Doyle; Kevin James ;   et al.
2010-06-10
Compounds, Compositions and Methods Comprising Thiazole Derivatives
App 20100099677 - Doyle; Kevin James
2010-04-22
Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
App 20090318429 - Doyle; Kevin James ;   et al.
2009-12-24
Compounds, Compositions and Methods Comprising Pyridazine Derivatives
App 20090270398 - Russell; Michael Geoffrey Neil ;   et al.
2009-10-29
Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
App 20090264481 - Jones; Graham Peter ;   et al.
2009-10-22
Compounds, Compositions and Methods Comprising Triazine Derivatives
App 20090264433 - Russell; Michael Geoffrey Neil ;   et al.
2009-10-22
Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
App 20090264441 - Jones; Graham Peter ;   et al.
2009-10-22
Compounds, Compositions and Methods Comprising Triazole Derivatives
App 20090264471 - Russell; Michael Geoffrey Neil ;   et al.
2009-10-22
Compounds, Compositions and Methods Comprising Isoxazole Derivatives
App 20090264486 - Jones; Graham Peter ;   et al.
2009-10-22
Cftr Inhibitor Compounds And Uses Thereof
App 20080269206 - Russell; Michael Geoffrey Neil ;   et al.
2008-10-30
Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents
Grant 6,900,216 - Doyle , et al. May 31, 2
2005-05-31
Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents
App 20030166628 - Doyle, Kevin James ;   et al.
2003-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed